One To Watch

Tenpoint Therapeutics

A UK-based biotech company pursuing vision-restoring engineered cell-based therapeutics and in vivo reprogramming to address degenerative ocular diseases.

Tenpoint launched in July 2023 with $70 million in series A financing, which will be used to develop the company's platform which is designed to replace multiple cell types lost to inherited and age-related conditions.

Want to Update your Company's Profile?